Ucb S.a.

UCB : announces new data at EADV 2026 supporting earlier use of BIMZELX (bimekizumab) for treating hidradenitis suppurativa

September 30, 2026

UCB : data presented at 2026 AANEM Annual Meeting and MGFA Scientific Session underscore leadership in advancing targeted treatments for gMG

September 29, 2026

UCB : receives U.S. FDA Breakthrough Therapy Designation for CIMZIA (certolizumab pegol) in pregnant women with antiphospholipid syndrome (APS)

September 9, 2026

UCB Comes to Agreement with U.S. Government to Lower the Cost of Medicine and Strengthen U.S. Manufacturing

August 31, 2026

UCB : Transparency notification Wellington Management Group LLP

August 31, 2026

UCB:EURONEXT

BE · EUR

Alternate listing for Ucb S.a.; the primary context on this page is UNC0:FWB.

UCBJY:OTC

US · USD

Alternate listing for Ucb S.a.; the primary context on this page is UNC0:FWB.

UNC:GETTEX

DE · EUR

Alternate listing for Ucb S.a.; the primary context on this page is UNC0:FWB.

UCBJF:OTC

US · USD

Alternate listing for Ucb S.a.; the primary context on this page is UNC0:FWB.

0NZT:LSIN

GB · EUR

Alternate listing for Ucb S.a.; the primary context on this page is UNC0:FWB.

UNC:XETR

DE · EUR

Alternate listing for Ucb S.a.; the primary context on this page is UNC0:FWB.

UNC:BX

CH · CHF

Alternate listing for Ucb S.a.; the primary context on this page is UNC0:FWB.

UNC:TRADEGATE

DE · EUR

Alternate listing for Ucb S.a.; the primary context on this page is UNC0:FWB.

852738:LS

DE · EUR

Alternate listing for Ucb S.a.; the primary context on this page is UNC0:FWB.

852738:LSX

DE · EUR

Alternate listing for Ucb S.a.; the primary context on this page is UNC0:FWB.

4UCB:EUROTLX

IT · EUR

Alternate listing for Ucb S.a.; the primary context on this page is UNC0:FWB.

UCB:VIE

AT · EUR

Alternate listing for Ucb S.a.; the primary context on this page is UNC0:FWB.